Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 11 Projects
Project # Contact PI Funding Organization Fiscal Year
Evaluating the effects of GLP-1 analog, oral semaglutide, as a treatment for sporadic behavioral variant frontotemporal dementia (bvFTD)
ADDF-33 Edison, Paul Alzheimer's Drug Discovery Foundation 2021
Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia
ADDF-34 Ducharme, Simon Alzheimer's Drug Discovery Foundation 2021
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
Can Lifestyle Changes Stop or Reverse the Progression of MCI Due to Early-Stage Alzheimer's Disease?
ADDF-37 Ornish, Dean Alzheimer's Drug Discovery Foundation 2021
Effects of Chaperone-Mediated Autophagy in Alzheimer's Disease
ADDF-39 Cermak, Jennifer Alzheimer's Drug Discovery Foundation 2021
MIB-626 For Treatment of Mild Dementia Patients
ADDF-43 Livingston, David Alzheimer's Drug Discovery Foundation 2021
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
Preserving NPTX2 and Memory in Alzheimer's Disease
ADDF-49 Worley, Paul Alzheimer's Drug Discovery Foundation 2021
In Vivo Characterization of a GABA-A alpha-5 Positive Allosteric Modulator
GC-201907-2019284 ROSENZWEIG-LIPSON, SHARON Alzheimer's Drug Discovery Foundation 2019
5th Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding
GC-201908-2019444 Cummings, Jeffrey Alzheimer's Drug Discovery Foundation 2019